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Abstract
Although the underlying neurobiology of major mental illness (MMI) remains unknown, emerging evidence implicates a
role for oligodendrocyte–myelin abnormalities. Here, we took advantage of a large family carrying a balanced t(1;11)
translocation, which substantially increases risk of MMI, to undertake both diffusion tensor imaging and cellular studies to
evaluate the consequences of the t(1;11) translocation on white matter structural integrity and oligodendrocyte–myelin
biology. This translocation disrupts among others the DISC1 gene which plays a crucial role in brain development. We show
that translocation-carrying patients display signiﬁcant disruption of white matter integrity compared with familial controls.
At a cellular level, we observe dysregulation of key pathways controlling oligodendrocyte development and morphogenesis
in induced pluripotent stem cell (iPSC) derived case oligodendrocytes. This is associated with reduced proliferation and a
stunted morphology in vitro. Further, myelin internodes in a humanized mouse model that recapitulates the human
translocation as well as after transplantation of t(1;11) oligodendrocyte progenitors were signiﬁcantly reduced when
compared with controls. Thus we provide evidence that the t(1;11) translocation has biological effects at both the systems
and cellular level that together suggest oligodendrocyte–myelin dysfunction.
Introduction
Schizophrenia (SZ) and other major mental illnesses (MMI)
such as bipolar disorder and major depression show high
heritability. Accumulating evidence from GWAS studies
points to a multifactorial polygenic inheritance, with
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individual genes conferring a modest increased suscept-
ibility, as well as pleiotropy [1]. In contrast, rare genetic
variants, such as a balanced chromosomal translocation in a
large Scottish family, that co-segregate with MMI show
high penetrance [2–6]. The range of psychiatric phenotypes
observed in people carrying the balanced t(1:11) translo-
cation suggests its study will be of considerable value for an
improved understanding of biological processes underlying
MMI. This translocation disrupts the DISC1 gene and
segregates with SZ and affective disorders in this large
family.
Despite multiple lines of evidence from pathological,
gene expression, and radiological studies, the role of glia is
understudied [2, 7–15]. As oligodendrocytes enable rapid
impulse propagation and provide trophic and metabolic
support to axons [16–19], their dysfunction is likely to
result in altered neuronal homeostasis. Further, the sole
protein-coding gene disrupted by the t(1;11) translocation;
Disc1, is known to affect the speciﬁcation and differentia-
tion of oligodendrocytes [20–22] in animal models. Hence a
direct study of the impact of the t(1;11) translocation on
oligodendrocytes is important. Furthermore, given the lim-
itations of animal models of neuropsychiatric disorders,
complementary models of human glia in the context of
MMI are particularly necessary. Indeed, recent studies using
patient derived iPS cells have shown impaired glial
maturation suggesting a causal link with SZ [23, 24].
A powerful approach to interrogate the structural and
cellular white matter consequences of the t(1;11) translo-
cation is to undertake combined water diffusion MRI
(dMRI) and biological studies of iPSC-derived oligoden-
drocytes from patients carrying the t(1;11) translocation.
Previous studies using iPSCs from individuals with DISC1
mutations and MMI have predominantly studied neural
precursor (NPCs) and/or neuronal processes [2, 25, 26].
Here, we demonstrate abnormalities of white matter integ-
rity using brain dMRI in t(1;11) translocation-carrying cases
compared with familial controls. In addition, case iPSC-
derived oligodendrocytes display cellular and structural
abnormalities in vitro as well as upon transplantation into
hypomyelinated mice. This study elucidates a cell biologi-
cal basis of oligodendrocyte–myelin deﬁcits in MMI. In
addition, we establish a human platform for future
mechanistic studies.
Results
Global changes in white matter structure and
connectivity due to the t(1;11) translocation
To begin to understand the effect of t(1;11) translocation at
a whole brain as well as cellular level, we used a multi-
tiered approach integrating patient and control whole brain
imaging, and in vitro and in vivo stem cell experi-
ments along with transgenic studies (Fig. 1a).
To study the impact of t(1;11) translocation on global
white matter structure and structural connectivity, we
undertook whole-brain probabilistic tractography using
dMRI on 21 individuals from the previously reported
Scottish family known to carry the t(1:11) translocation of
whom eight were carriers of the t(1;11) translocation [27].
All eight carriers had a psychiatric diagnosis; one with SZ,
four with major depression (MDD), three with cyclothymia
while only 1 of the 13 family members without the t(1;11)
translocation, had a psychiatric diagnosis [27]. The affected
noncarrier however is described to carry modiﬁer loci on
chr11q2 and chr5q that might contribute to the development
of MMI (described in [28]). High-resolution T1-weighted
structural and dMRI data were combined to create structural
connectivity matrices of each participant’s brain. In these
matrices (Fig. 1b–e), the 85 gray matter regions, parcellated
from the structural MRI data, are the nodes of the brain
structural network while the connecting white matter path-
ways, identiﬁed from whole brain dMRI tractography, are
its edges. The edge connection strength between nodes is
obtained by recording the mean fractional anisotropy (FA),
a measure of white matter microstructure, along tracto-
graphy streamlines connecting all ROI (network node) pairs
(Fig. 1b–e). Global graph theory measures of brain struc-
tural connectivity, such as network degree (number of
connections one node has to other nodes), network strength
(the average sum of edge connections per node), and global
efﬁciency (the average of the inverse shortest path length
between nodes), can then be calculated for each subject and
compared across populations to assess differences in brain
structure. In our case, we hypothesized that carriers have
reduced connectivity (e.g., lower degree, strength, and
global efﬁciency) than noncarriers. We estimated the effect
of translocation status (carrier versus non-carrier) and
age on global connectivity measures using a Markov
chain Monte Carlo (MCMC) approach [29]. Signiﬁcant
differences between carriers and non-carriers were found
for global network degree (posterior mean=−1.81; 95%
CI= [−3.43, −0.34]; pMCMC= 0.02) and global
network strength (posterior mean=−1.64; 95% CI=
[−3.09, −0.22]; pMCMC= 0.03) (Fig. 1f, g). Global net-
work efﬁciency showed a tendency towards signiﬁcance
(posterior mean=−1.19; 95% CI= [−2.65, 0.26];
pMCMC= 0.09) while clustering coefﬁcient was not sig-
niﬁcantly different between groups (posterior mean= 0.93;
95% CI= [−2.64, 0.59]; pMCMC > 0.05) (Data not
shown). Together these ﬁndings show that carriers have
reduced structural connectivity compared with controls and
are consistent with t(1;11) translocation causing widespread
changes in white matter structural integrity.
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Fig. 1 Global changes in structural networks and connectivity in t
(1;11) carriers. a Overview of the approach used in this study to
investigate the effect of t(1,11) on oligodendrocyte development and
myelination capability. Brain imaging of control and affected t(1,11)
carriers was undertaken to identify differences in connectivity. Sepa-
rately, patient derived iPSCs were differentiated towards oligoden-
droglial fate to study developmental differences. A combinatorial
approach of cellular phenotyping along with transcriptomic analysis
was employed. Finally, the myelination capability was studied in
transgenic mice (Der1/+) recapitulating the human mutation as well as
by transplanting hiPS derived OPCs into a hypomyelinated mouse
model (MBPShi/Shi; Rag2−/−). b–e Average FA-weighted structural
networks (a, b) and connectivity matrices (c, d) for controls (b, d) and
carriers (c, e) obtained using diffusion and structural MRI. Network
nodes were identiﬁed from high-resolution T1-weighted volume scans
using Freesurfer (http://freesurfer.net), with connecting edges created
using probabilistic tractography (bedpostx/probtrackx; http://fsl.fmrib.
ox.ac.uk/fsl) from high angular resolution diffusion MRI data. In
b, c network nodes are colored to indicate gray matter in different
lobar structures, while in d, e stronger connections between different
cortical regions are indicated by lighter yellow colors. Careful exam-
ination of the connectivity matrices show that a number of connections
have higher FA in d than e suggesting that brain connectivity is
increased in controls compared with carriers. (f, g) Quantiﬁcation of
Global network degree (f) and Global network strength (g) from
d, e shows statistically signiﬁcant changes in carriers (n= 13 controls
and eight translocation carriers, Markov chain Monte Carlo (MCMC)
test). Median with upper and lower quartiles is shown. The whiskers
depict the range. Cases studied using iPS cells in this particular study
have been highlighted
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Altered differentiation and gene expression in t
(1;11) derived oligodendroglia
In order to begin to determine the cellular and molecular
basis underlying the observed abnormalities in white matter
integrity, we next studied oligodendrocytes from affected
and unaffected individuals—see Suppl. Table 1. iPSC lines
were established, using an episomal non-integrating
method, from four individuals carrying the mutation (Case
1—cyclothymia, Case 2—MDD, Case 3—MDD, Case 4—
SZ; see Supplementary table 1) and three unaffected family
controls (Supplementary Fig. 1). H3K27 trimethylation
staining indicated typical X-chromosome inactivation in the
female iPSC lines as seen by distinct foci in the nucleus
while the male lines showed diffuse staining (Supplemen-
tary Fig. 2). We generated enriched oligodendrocyte lineage
cells using a previously described protocol [30] (Fig. 2a–c).
Quantitative analysis showed no difference in progenitor
speciﬁcation as assessed by OLIG2+ staining on day 1
(Fig. 2d). Developmentally, OLIG2+ NPCs in the cortex
give rise to PDGFRα+ oligodendrocyte precursor cells
(OPCs) which differentiate into O4+ and MBP+ pre-
myelinating oligodendrocytes. In contrast, there was a sig-
niﬁcant reduction in PDGFRα+ cells in cases compared
with controls at 7 days post plating (Controls: 8.27 ± 0.50%
Cases: 5.61 ± 0.71%, n= 3 independent conversions,
p < 0.05 unpaired t-test) and a concomitant signiﬁcant
increase in O4+ cells in case-derived lines compared with
controls at 3 weeks differentiation (Controls: 63.42 ± 1.3%
Cases: 73.7 ± 2.5%, n= 3 independent conversions, p <
0.05 unpaired t-test) suggesting increased differentiation of
OPCs in case lines (Fig. 2e, f). On analyzing the case lines
individually, we observed that the reduction in PDGFRα+
cells and increase in O4+ cells was limited to Case3 and
Case4 and not seen in other lines (Supplementary
Fig. 3a–c). We conﬁrmed the reduction in proliferation in
Case3 and Case4 OPCs by labeling dividing cells with EdU
and co-staining for PDGFRα (Supplementary Fig. 3d–f).
Control and Case lines showed equal proportions of TUJ1+
or GFAP+ cells at 3 weeks (Supplementary Fig. 4a, c).
Case lines however had a lower proportion of proliferating
Ki67+ cells at the end of week 3 (Controls: 12.30 ± 2.8%
Cases: 5.54 ± 1.2%, n= 3 independent conversions, p <
0.05 unpaired t-test), in keeping with premature differ-
entiation (Supplementary Fig. 4b, c). A short-term decrease
in expression of full-length DISC1 mRNA has been pre-
viously linked to premature NPC differentiation [26, 31].
We found that full-length DISC1 mRNA expression was
signiﬁcantly reduced in case iPSCs and case-derived OPCs
compared with control samples (OPCs: Controls: 0.72 ±
0.10, Cases: 0.22 ± 0.05, n= 3 independent conversions,
p < 0.05 One-way ANOVA with Holm–Sidak’s correction)
(Supplementary Fig. 4d).
To begin to understand the molecular consequences of
the translocation on oligodendrocytes, we next undertook
RNA-seq analysis on differentiated week 3 oligodendrocyte
cultures. We compared three cases and two control lines by
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Fig. 2 Efﬁcient conversion of control and case iPS cells to oligoden-
droglial lineage. a1–a7 Both control and case iPS lines could be
patterned to OLIG2+ precursor cells under conditions described in
Methods. b1–b7 Further differentiation of cells from a gave PDFGRα
+ OPCs under proliferative conditions containing FGF2 and PDGF-
AA. c1–c7 Removal of mitogens produced mature oligodendrocytes
that co-stained for O4 and MBP. d–f Quantiﬁcation of OLIG2+ cells
on day1 (d) PDFGRα+ OPCs on day7 (e) and O4+ oligodendrocytes
at day21 (f) shows a signiﬁcant increase in oligodendrocytes in case
lines (n= 3 independent conversions for each line, unpaired t-test used
to analyze p-values). Scale: a–c 50 μm
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paired-end RNA sequencing on an Illumina platform. By
setting an adjusted p-value of <0.05, we identiﬁed 228
genes (164 upregulated and 64 downregulated) (Fig. 3a).
Gene ontology (GO) analysis identiﬁed novel candidate
pathways dysregulated in MMI (Fig. 3b). The differentially
regulated genes included those relating to nervous system
development, homophilic cell adhesion via plasma mem-
brane, galactosylceramide biosynthetic process, activation
of GTPase activity, calcium ion binding, and myelination
(Fig. 3b, c). Genes involved in oligodendrocyte differ-
entiation, actin binding, and ion-transmembrane transport
such as NKX2-2, ZNF804A, SLC8A3, and CTTNBP2
despite not being enriched in GO analysis were also found
to be dysregulated in t(1;11) carrying lines (NKX2.2 Con-
trols: 1.0 ± 0.46 Cases: 7.16 ± 4.41; ZNF804A Controls:
2.13 ± 1.27 Cases: 25.31 ± 24.39: SLC8A3 Controls: 1.22 ±
0.44 Cases: 9.56 ± 5.71; CTTNBP2 Controls: 1.04 ± 0.37
Cases: 5.09 ± 3.28, n= 3 independent conversions, p < 0.05
F-test of variance). Beta-actin mRNA levels did not sig-
niﬁcantly differ between cases and controls (Supplementary
Table 4). In addition, genes involved in myelin formation
and wrapping such as galactosylceramide biosynthetic
protein GAL3ST1 (GAL3ST1 Controls: 2.40 ± 1.48 Cases:
19.98 ± 23.76; n= 3 independent conversions, p < 0.05
F-test of variance) were also dysregulated in t(1;11)
translocation-carrying lines (Fig. 3d).
In vitro morphology as well as in vivo internodal
length is severely affected in t(1;11) carrying
oligodendrocytes
In support of the dysregulation of actin-related genes in case
lines, DISC1 has previously been shown to affect micro-
tubule organization and neurite outgrowth [32, 33]. In
Fig. 3 Transcriptomic analysis
of case oligodendrocytes
implicate genes involved in
nervous system development,
activation of GTPase activity,
galactosylceramide biosynthesis,
myelination, and calcium ion
binding. a Differentially
expressed genes (FDR 5%) were
found after adjusting for
multiple statistical tests. As a
result, 64 and 164 genes were
found down and upregulated,
respectively. b Dysregulated
pathways identiﬁed by Gene
Ontology (GO) analysis of
RNA-seq results. Of note are
pathways implicated in nervous
system development, activation
of GTPase activity,
galactosylceramide biosynthesis,
myelination, and calcium ion
binding. c Heat-maps showing
differences in expression
between controls and cases for
key genes in oligodendrocyte
differentiation, Actin binding,
and Ion-transmembrane
transport. d qRT-PCR validation
of genes selected after RNA-seq
analysis (n= 3 independent
conversions, p < 0.05 F-test for
comparing variances)
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oligodendrocytes, this is likely to affect morphological
development and myelin formation. Case-derived O4+
oligodendrocytes were found to be severely stunted and
dysmorphic in comparison to familial controls (Fig. 4a), a
ﬁnding conﬁrmed by quantiﬁcation of surface area covered
by individual oligodendrocytes (Fig. 4b) (Controls: 2170
μm2 ± 179.3, Cases: 1495 μm2 ± 173.6, p < 0.05 unpaired
t-test, n ≥ 30 cells per line from three independent conver-
sions). The reduction in surface area was prominent across
the case lines with the exception of Case 1 which did not
show a signiﬁcant change (Supplementary Fig. 5a, b). Sholl
analysis also showed a severe reduction in oligodendrocyte
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process complexity (Fig. 4c). To evaluate whether this
in vitro phenotype might be replicated in an in vivo context
we next examined a novel mouse model engineered to
model the effects of the t(1;11) translocation on DISC1
expression [34]. This mouse mimics the translocation-
induced gene fusion that abolishes full-length DISC1
expression from one allele and produces chimeric tran-
scripts encoding deleterious truncated/chimeric forms of
DISC1 from the derived chromosome 1 [34, 35]. Here,
upon co-staining for MBP, a myelin marker, and CASPR, a
paranodal marker, in mouse cortices at postnatal day 21
(Fig. 4d, e), we found a signiﬁcant reduction in internode
lengths in the cortical layers of Der1/+ mutant mice (WT:
33.99 ± 0.93 μm, Der1/+: 21.72 ± 0.37 μm, n= 3 mice
each, >190 internodes per genotype; p < 0.05 t-test with
Welch’s correction) (Fig. 4f). Analysis of individual mye-
linated axons using electron microscopy however did not
show any difference in g-ratio or in the frequency of
myelination (Fig. 4g–i) (n= 4 mice each). To assess the
number of myelin sheaths produced by a single oligoden-
drocyte as well as their respective lengths, we performed
immunoﬂuorescence for CNPase to stain entire oligoden-
drocytes and hence allow for tracing processes from the cell
body to myelin sheaths. Employing this technique, we
analyzed oligodendrocytes in the sparsely myelinated layers
II/III of the medial prefrontal cortex of 6 weeks old mice
(Fig. 4j). Here we found that the number of myelin sheaths
produced by a single cell was signiﬁcantly increased in
heterozygous Der1 mice when compared with wild-type
littermates (WT: 42.57 ± 2.46, Der1/+: 49.50 ± 1.51, n= 4
mice each, 28 cells per genotype; p < 0.05 t-test) (Fig. 4k).
In addition, in agreement with our in vitro analysis the
average length of internodes produced by single oligoden-
drocytes was signiﬁcantly reduced in heterozygous Der1
mice (WT: 66.94 ± 1.80 μm, Der1/+: 60.63 ± 2.71 μm, n=
4 mice each, 28 cells per genotype; p < 0.05 t-test) (Fig. 4l).
To next evaluate the in vivo consequences of t(1;11)
mutation on human oligodendrocytes we established human
glial chimeras by transplantation of t(1;11) and control glial
cells into neonatal hypomyelinated immune-deﬁcient mice
(MBPshi/shi; Rag2−/−). Neonatal animals (P1-P2) were uni-
laterally injected with case (Case 2 and Case 4) or control
(Control 1 and Control 2) derived OPCs (200,000 cells per
injection) into the developing neocortex and analysed at 8-
and 13-weeks post transplantation—the latest time-point
allowed by animal regulations—by staining for MBP,
GFAP, and human nuclei (hNu). Human cells were found in
the corpus callosum around the site of injection where they
expressed either MBP or GFAP (Fig. 5a, b). In addition,
cells had also crossed the midline and differentiated. Myelin
sheath lengths were greatly reduced in case-derived oligo-
dendrocytes (Fig. 5c–f, Supplementary Fig. 5c, d) with a
majority of myelin sheaths (56% for Case 2 and 48% for
Case 4) between 5 and 10 μm. In comparison, only 10% of
control oligodendrocytes fell in that range (Supplementary
Fig. 5e). Indeed, mean sheath length showed a signiﬁcant
difference both at 8- and 13-weeks post transplantation
(8 weeks Controls: 23.20 ± 0.84 μm Cases: 9.48 ± 0.26 μm,
n= 6 mice each and 281, 320 segments measured, respec-
tively p < 0.001 unpaired t-test with Welch’s correction;
13 weeks Controls: 29.44 ± 1.39 μm Cases: 20.24 ± 0.76
μm, n= 3–6 mice and 269, 145 segments measured,
respectively, p < 0.05 unpaired t-test with Welch’s correc-
tion,) (Fig. 5g, h). Together the mutant mice and human
transplantation studies reveal reduced myelin internode
formation associated with the t(1;11) translocation.
Discussion
In this study we provide converging lines of evidence from
human imaging, molecular, and cellular analysis including
of chimeric mice that suggests that the t(1;11) translocation
causes oligodendrocyte–myelin deﬁcits.
The results from structural connectivity, measured using
graph theory analysis are consistent with t(1;11) transloca-
tion dependent widespread changes to white matter con-
nectivity. It has previously been shown that family members
Fig. 4 Case-derived oligodendrocytes are morphologically impaired
in vitro and, in a mouse-model recapitulating the translocation.
a O4 staining of week 3 oligodendrocytes shows decreased cellular
size and complexity of case-derived cells. b Quantiﬁcation of cellular
area showing the effect of t(1;11) translocation among different case-
derived oligodendrocytes. n= 95 for control (three lines) and 120 for
case (4 lines) oligodendrocytes. Mean ± SEM shown with paired t-test
used for assessing statistical signiﬁcance (p-value < 0.01). c Case oli-
godendrocytes have simpler morphology with fewer branch points
away from the cell soma as assessed by Sholl analysis. Mean values
shown and unpaired t-test used to assess statistical signiﬁcance
(p-value < 0.001). d Low magniﬁcation image of myelin basic protein
(MBP) staining in the P21 Der1/+ cortex shows absence of gross
cortical abnormalities. (Ctx cerebral cortex, Str striatum, CC corpus
callosum). e Reconstructions of myelinated segments of upper cortical
layer neurons from boxed region in a of wild-type (+/+) and Der1
heterozygous (Der1/+) brains stained for MBP and paranodal protein
Caspr. Arrowheads demarcate myelin segments used for quantiﬁca-
tion. f Graph showing internodal length measurements from b. Each
data point represents one myelin segment and the graph contains
pooled data from n ≥ 50 segments each from three animals per geno-
type. p < 0.05 Unpaired t-test with Welch’s correction. g–i Electron
microscopy analysis of the corpus callosum of wild-type and Der1/
+mice (g) shows that thickness of myelin (h) and the relative fre-
quency of myelinated ﬁbers (i) are not affected due to the transloca-
tion. More than 250 axons measured in each group from 4 animals per
genotype. j–l Single-oligodendrocyte analysis using by CNPase
staining j at P42 supports ﬁndings in e, f and shows an increase in
number of processes per oligodendrocytes (k) but a decrease in
internodal length (l). Each data points represents one cell and the
graph contains pooled data from n= 28 cells each from 4 animals per
genotype. p < 0.05 Unpaired t-test. Scale bars: a 20 μm, d 500 μm,
e 10 μm, g 1 µm, j 20 µm
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who carry the balanced translocation have a pattern of
cortical thinning similar to that observed in patients with SZ
[36]. Here, we provide evidence of disruption of white
matter topology and organization building on earlier voxel-
based ﬁndings from ourselves showing a link between FA
values and psychotic symptoms in those with the t(1;11)
translocation [37] and between white matter organization,
genetic risk markers, and cognition in the patients with
“idiopathic” SZ scanned as part of the same project [38].
The recent large ENIGMA SZ diffusion tensor
imaging study of over 4000 individuals has recently shown
white matter microstructural differences in SZ [39] and it is
likely that the t(1;11) translocation causes an altered reg-
ulation of SZ candidate genes and the DISC1 core inter-
actome [40].
There has been much debate about the importance of
DISC1 as a genetic risk factor for SZ [41, 42] and it is more
appropriate to instead classify DISC1 as a genetic risk factor
for MMI with a broad clinical phenotype. As such, DISC1
interacts with many protein partners and mechanistically
affects several neurodevelopmental pathways despite not
being identiﬁed as having a clear association with SZ from
genome-wide studies [1]. This is exempliﬁed from the
clinical phenotypes of the four affected carriers in this
study, one with SZ and three with affective disorders.
Interestingly, OPCs and oligodendrocytes derived from a
juvenile-onset, treatment resistant individual showed severe
developmental, structural, and functional changes across
tests (Case 4; described in Supplementary Table 1). In
contrast, cells derived from individuals presenting a less
severe symptomatology (as in Case 1) also showed com-
paratively milder changes in vitro. This both highlights the
need for multiple patient lines as well as the promise of iPS-
based systems to model aspects of disease variation. The
use of several iPS lines allows stratiﬁcation based on cel-
lular or gene expression changes as well as identiﬁcation of
common phenotypes to aid drug-screening approaches. In
line with this, we uncovered shared gene expression chan-
ges across patient lines.
Robust and comparable differentiation of case lines
compared with familial controls showed that the transloca-
tion does not interfere with early speciﬁcation and pattern-
ing of cells to the oligodendroglial lineage. Case lines
however, showed premature cell cycle exit of OPCs, a
ﬁnding consistent with reports for cortical neurons derived
from DISC1 exon 8 interrupted iPSC lines [26] and sup-
ported also by the observed increased expression of
NKX2.2, ZNF488, and SLC8A3 genes. Of these, NKX2.2
and ZNF488 are described to be speciﬁc to the oligoden-
droglial lineage as well as having a pro-differentiation effect
on OPCs [43–45]. Thus, their increased expression in our
dataset is consistent with the observed phenotype of
Fig. 5 Case and control OPCs transplanted neonatally in the hypo-
myelinated show reduction in myelin sheath length at 8- and 13-weeks
post transplantation. a, b Human OPCs transplanted into MBPShi/Shi;
Rag2−/− neonates (at P1−P2) efﬁciently engraft and differentiate to
oligodendrocytes (arrowhead in a) and astrocytes (arrow in b) in the
white matter (dotted lines) by 8 weeks. Human cells are identiﬁed by
immunoreactivity against human nuclei (red) and MBP (green) in
a and with human GFAP (red) and MBP (green) in b. c–f Individual
human oligodendrocytes from Control 1 and 2 (c, d) and Case 2, 4
lines (e,f) were imaged and length of myelin segments measured.
Arrowheads demarcate the beginning and end of individual myelin
segments visualized in 3D. g–h Quantiﬁcation of average myelin
sheath lengths from c–f shows a severe reduction in cases at 8 weeks
(g) and 13 weeks post transplantation (h). Mean with upper and lower
quartiles shown. Scatter points represent outliers. p < 0.05 Unpaired
t-test with Welch’s correction, 8 weeks: n= 3 mice injected with each
cell line were analyzed; >40 segments measured per mouse and
cumulatively 281 and 320 segments measured, 13 weeks: n= 1, 2, 3, 4
mice injected with control 1, control 2, case 2, case 4, respectively
were analyzed; >20 segments measured per mouse and cumulatively
269, 145 segments were measured in control and case injected mice,
respectively. CC corpus callosum, hNuclei human nuclei, MBP myelin
basic protein, CASPR contactin associated protein 2, hGFAP human
glial ﬁbrillary acid protein. Scale bars: a, b 50 μm, c–f 20 μm,
respectively
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precocious differentiation. Our analysis also highlights
genes identiﬁed via GWAS studies and implicated in psy-
chosis (ZNF804A) [46] and suicidal behavior (SKA2) [47].
In addition, several genes (UGT8, GAL3ST1, ZNF488,
CTTNBP2, SLC8A3, GRIA4, and KCND2) identiﬁed in our
analysis agree with a recent study of glial progenitors from
childhood onset SZ patient-derived iPSC lines [23]. This
study of humanized glial chimeric mice suggests a potential
causal role for impaired glial progenitor cell differentiation
and found premature migration of GPCs, reduced white
matter expansion, and hypomyelination relative to controls
as well as deﬁcits in astrocyte differentiation and mor-
phology [23]. This points towards convergent mechanisms
for oligodendrocyte dysfunction in MMI despite differences
in genetic basis. Future studies employing functional
genetics approaches such as CRISPR and siRNA mediated
knockdown could clarify the role of these genes in the
pathophysiology.
Our ﬁnding of dysregulation of actin associated genes, is
of considerable interest noting that DISC1 has been shown
to play a role in microtubule reorganization and neurite
outgrowth [33]. In keeping with these ﬁndings, we observed
case-derived oligodendrocytes to have a morphological
phenotype of shorter and less complex processes. Critically,
we also observed in the Der1 mouse model, that recapitu-
lates the effects of the human translocation upon DISC1
expression, shorter internodes that were further supported
by a reduction in myelin segment length found upon
transplantation of case and control-derived OPCs into
hypomyelinated mice. Transgenic rodent models of Disc1
have shown a range of anatomical changes including cere-
bral cortical thinning, reduced neurite outgrowth as well as
behavioral changes (reviewed in [48]) but ﬁner structure
deﬁcits in myelination have thus far not been shown. A
crucial role for the actin remodeling pathway in myelination
has been described [49–51] and could serve as an
important pharmacological target in future studies.
Finally, our study also points towards a galactolipid
imbalance in case-derived oligodendrocytes leading to
myelin defects. In keeping with this, mice genetically
altered for galactolipid pathway genes present neurological
manifestations due to altered axo–glia interactions and
unstable myelination [52–54]. Together these ﬁndings are
consistent with t(1;11) translocation dependent
oligodendrocyte–myelin dysfunction.
The future evaluation of in vivo functional consequences
of shorter internodes would be of great interest since shorter
internodes are associated with reduced conduction velo-
cities and even degenerative changes. This is particularly
relevant when considering that gamma oscillations between
different brain regions are known to be affected in MMI.
Parvalbumin expressing interneurons, the major cell-type
thought to regulate gamma oscillations are extensively
myelinated [55, 56] and its disruption could potentially
contribute to the development of MMI.
In summary, our ﬁndings here of reduced white matter
connectivity in t(1:11) translocation carriers add to the
growing evidence of white matter deﬁcits observed in MMI
[57] and suggest that oligodendroglia play an important role
in the underlying pathophysiology of MMI.
Material and methods
Participants
Individuals with and without the t(1;11) translocation were
recruited from a previously reported extended Scottish
family. The t(1;11) translocation status of family members
was originally ascertained by karyotyping and these were
extended in subsequent studies. Researchers within the
Division of Psychiatry have been in contact with members
of the family for many years and through them other
members of the family were invited to participate. The
study was approved by the Multicentre Research Ethics
Committee for Scotland. A detailed description of the study
was given and written informed consent was obtained from
all individuals prior to participation. A summary of the
individual participants in this study, their translocation
status, diagnosis, and medication at the time of biopsy is
given in Supplementary Table 1. Psychiatric diagnoses were
established by consensus between two trained psychiatrists
according to DSM-IV (TR) criteria. Diagnostic information
was obtained by a face-to-face semi-structured interview
using the Structured Clinical Interview for DSM-IV sup-
plemented by reviews of hospital records and collateral
information from hospital psychiatrists and general practi-
tioners. The operational criteria symptom checklist was
completed based on psychiatric case notes and
interview data.
MRI imaging and analysis
All imaging data were collected on a Siemens Magnetom
Verio 3T MRI scanner running Syngo MR B17 software
(Siemens Healthcare, Erlangen, Germany). For each sub-
ject, whole-brain dMRI data were acquired using a single-
shot spin-echo echo-planar imaging sequence with
diffusion-encoding gradients applied in 56 directions (b=
1000 s/mm2) and six T2-weighted (b= 0 s/mm2) baseline
scans. Fifty-ﬁve 2.5-mm-thick axial slices were acquired
with a ﬁeld-of-view of 240 mm and matrix 96 × 96 giving
2.5 mm isotropic voxels. In the same session, a 3D T1-
weighted inversion recovery-prepared fast spoiled gradient-
echo volume was acquired in the coronal plane with 160
contiguous slices and 1 mm isotropic voxel resolution.
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Image processing and tractography is described in Supple-
mentary Methods.
Animal ethics
All animal experiments were conducted in accordance with
the UK Animals (Scientiﬁc Procedures) Act (1986). Shi-
verer mice (C3Fe.SWV-Mbpshi/J; 001428) were purchased
from Jackson Laboratories. MBPShi/Shi; Rag2−/− homo-
zygous males were crossed with MBPShi/+; Rag2−/− het-
erozygous females to obtain 50% double homozygous pups.
Der1 heterozygous animals and control littermates were
obtained by crossing wild-type males with heterozygous
females. The date of vaginal plug was observed as E0.5 and
embryos timed accordingly. All mice were maintained on a
C57BL/6J background on a reversed 12-h light cycle with
ad libitum access to food and water.
Shiverer, Rag2, and Der1 mice were identiﬁed by gen-
otyping from tail/ear-clips using the following primers (in
5′–3′ orientation):
Mbp_F TCC CTG GTG GCA GCT ATG AGC AGA
CAC TGA
Mbp_R CCC CGT GGT AGG AAT ATT ACA TTA
CCA GCT
Shi_F AGG GGA TGG GGA GTC AGA AGT GAG
GAA AGA
Shi_R ATG TAT GTG TGT GTG TGC TTA TCT
AGT GTA
Rag2_F GGT CAT CCT TTG CAA CAC AG
Rag2_M CAG CGC TCC TCC TGA TAC TC
Rag2_R TGC ATT CCT AGA GCG TCC TT
Disc1_F CCT GCA TCC ACA GAC GTG C
Disc1_R CAG TAG TAA GAA AAG AGA
CAA CCC CC
Disc1_M ATA ACG GTC CTA AGG TAG CGA GC
Mouse model of t(1;11) translocation
This mouse line is described in [34]. Brieﬂy, to generate a
complementary model of the translocation that mimics its
effects upon DISC1 expression, the endogenous mouse
Disc1 locus was genetically engineered using Regeneron’s
GEMM platform (VelociMouse®). The mouse Disc1 allele
in C57BL/6 × 129/Sv ES cell clones was targeted by delet-
ing ~98.5 kb of genomic DNA encompassing exons 9–13,
thus removing the 3′ half of the gene that is translocated to
chromosome 11 in human t(1;11) carriers. This was replaced
with ~114 kb of human chromosome 11 genomic DNA
containing exons 4–7 of the DISC1FP1 gene, corresponding
to the region of the gene that is translocated to chromosome
1 in t(1;11) carriers. The edited endogenous mouse Disc1
locus thus mimics the DISC1/DISC1FP1 gene fusion event
on the derived chromosome 1 in t(1;11) carriers.
CNPase single-oligodendrocyte tracing
For CNPase immunoﬂuorescence studies, female mice were
transcardially perfused with 4% PFA at 6 weeks of age.
Brains were cut into 100-µm coronal sections on a vibra-
tome (Leica). Free-ﬂoating sections containing the medial
prefrontal cortex were blocked and permeabilized with 10%
normal goat serum in 0.25% Triton X-100/PBS and sub-
jected to antigen retrieval in 0.05% Tween20/10 mM tri-
sodium citrate (pH 6.0) at 95 °C for 20 min. Subsequently,
sections were washed in PBS, blocked as above, and
incubated with primary mouse anti-CNPase antibody (Atlas
antibodies; 1:2000) in blocking buffer for 24 h at 4 °C.
Thereafter, sections were washed in PBS, incubated with an
Alexa Fluor 488-labeled secondary antibody raised in goat
(Invitrogen; 1:000) for 24 h at 4 °C, and Hoechst33258
(5 µg/ml) for 20 min to label nuclei. After ﬁnal washes in
PBS, sections were mounted on slides and z-stack images
through the whole section were taken using a Leica SP8
confocal microscope. Images were analyzed blind to gen-
otype by assigning random numbers to the animals and
using the ImageJ simple neurite tracer plugin.
Neonatal transplantation of OPCs into MBPShi/Shi;
Rag2−/− mice
Homozygous MBPShi/Shi; Rag2−/− pups between P1-P2
were anaesthetized with isoﬂurane and maintained on a
heat-mat for the duration of the transplantation. Dissociated
case and control-derived OPCs at day 51 (day 0= iPSCs)
were delivered (200,000 cells in 2 μl) using a Hamilton
syringe (Hamilton Company) through the skull. Transplants
were directed at the presumptive corpus callosum and sur-
rounding cortex. Pups were transcardially perfused with 4%
paraformaldehyde at 8- and 13-weeks post injection and
brains collected for histology. Three to four mice were
transplanted per line.
Electron microscopy
For electron microscopy, male and female mice at the age of
3 weeks were anesthetised and intracardially perfused with
4% paraformaldehyde/2% glutaraldehyde in 0.1 M phos-
phate buffer. After overnight post ﬁxation, brains were cut
into 1-mm-thick coronal sections using a brain slicer. Sec-
tions between Bregma 1.0 and −1.0 were trimmed further
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to isolate the medial aspect of the corpus callosum in a 1
mm × 2mm × 1mm block (L ×W ×H). Tissue samples
were ﬁxed in perfusion buffer for 24 h and 1% OsO4 in
0.1 M phosphate buffer for 30 min. Using an automated
processor (Leica), samples were dehydrated in rising con-
centrations of Ethanol, incubated in propylene oxide and
rising concentrations of resin (TAAB laboratories) in pro-
pylene oxide before being embedded in resin and hardened
for 22 h at 60 °C. Ultrathin sections were produced and
analysed with a TEM-1400 Plus (Joel).
Induced pluripotent stem cell line maintenance
All iPSC were derived from human donor dermal skin
ﬁbroblasts using integration-free episomal methods [58].
iPS lines were maintained in Matrigel (BD Biosciences)
coated plastic dishes in E8 medium (Life Technologies) at
37 °C and 5% CO2.
Karyotyping, pluripotency markers, and X-
chromosome inactivation staining
Standard G-banding chromosome analysis was performed
to conﬁrm chromosome number and gross genetic
abnormalities over the course of this study. Pluripotency of
case and control iPS lines was conﬁrmed by staining for
SOX2, OCT3/4, and TRA1-60. X-chromosome inactivation
in female iPSC lines was conﬁrmed by staining for H3K27
trimethylation marks [59].
OPC and oligodendrocyte generation
Derivation of NPCs was performed as described [30, 60]
(also described in Supplementary Methods). Brieﬂy, NPCs
were cultured in suspension as neurospheres in Advanced
DMEM/F12 containing: 1% N-2 supplement, 1%
B27 supplement, 1% Anti-anti, 1% GlutaMAX (all from
Life Technologies), FGF2 20 ng/ml (PeproTech), PDGFα
20 ng/ml (PeproTech), purmorphamine 1 μM (Calbiochem),
SAG 1 μM (Calbiochem), IGF-1 10 ng/ml (PeproTech), and
Tri-iodothyronine (T3) 30 ng/ml (Sigma) for 6–12 weeks.
Following papain dissociation of neurospheres (Worthing-
ton), cells were plated on 1/100 diluted Matrigel (BD
Biosciences), 20 µg/ml Fibronectin (Sigma), and 10 µg/ml
Laminin (Sigma) coated coverslips or plates at a density of
20,000–30,000 cells per 0.3 cm2. Differentiation of oligo-
dendrocytes was achieved by mitogen withdrawal (except
for T3 and IGF-1).
RNA sequencing
Library preparation, sequencing, and analysis are described
in detail in Supplementary methods. Sequencing reads will
be made available via ArrayExpress or European Genome-
Phenome Archive prior to publication.
Quantitative real-time PCR (qRT-PCR)
RNA was extracted from cell pellets using the RNeasy Mini
kit (QIAGEN). Five hundred nanograms of RNA was used
to prepare cDNA by random hexamer extension using
MMuLV reverse transcriptase (ThermoFisher) according to
the manufacturer’s instructions.
Gene speciﬁc primers were used in a 96-well plate for-
mat to quantify differences in cDNA levels using a BioRad
CFX96 qPCR machine. ΔΔCt method was used to nor-
malize and quantify relative fold changes in gene
expression.
Primers used in this study were (in 5′–3′ orientation):
DISC1_F CCA GCC TTG CTT GAA GCC AAA A
DISC1_R TGA GGA GTC CCT CCA GCC CTT C
GAL3ST1_F CAA GAC CCG GAT CGC TAC TAC
GAL3ST1_R TGT CAT AGC CCA GGT CGA AGA
SLC8A3_F CTG CAC CAT TGG TCT CAA AGA
SLC8A3_R GCG TCT GCA TAT ACA TCC TGG A
NKX2.2_F GTC AGG GAC GGC AAA CCA T
NKX2.2_R GCG CTG TAG GCA GAA AAG G
CTTNBP2_F AAG AGC GTG GCA AGA ACA AG
CTTNBP2_R TGG GCC TCC TCT ATG ACT TTG
ZNF804A_F AGT GGC CCC ATG TTC AAA TCA
ZNF804A_R CCA CAA CAA CTC GTT GGG AAA T
GAPDH_F GAG TCC ACT GGC GTC TTC AC
GAPDH_R ATG ACG AAC ATG GGG GCA T
β-ACTIN_F CAC CTC CCC TGT GTG GAC TTG GG
β-ACTIN_R GTT ACA GGA AGT CCC TTG
CCA TCC
Immunocytochemistry
All steps were performed at ambient temperature. Cells
were ﬁxed with 4% paraformaldehyde in PBS for 5 min,
permeabilized with 0.1% Triton X-100 containing PBS
(except for PDGFRα and O4), blocked in 3% goat serum,
and incubated with appropriate primary and secondary
antibodies (Alexa Fluor conjugated; Life Technologies).
Nuclei were counterstained with DAPI (Sigma) and cov-
erslips were mounted on slides with FluorSave (Merck).
Fields were selected based upon uniform DAPI staining and
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imaged in three channels. Antibodies; OLIG2 (1:200, Mil-
lipore), PDGFRα (1:500, Cell Signaling), O4 (1:500, R&D
Systems), MBP (1:50, Abcam), GFAP (1:500, DAKO),
GFAP (1:500, Cy3 conjugated; Sigma), CASPR (1:1000,
Abcam), Sox2 (1:1000, Abcam), Oct3/4 (1:250, Santa
Cruz), Nanog (1:100, R&D Systems), TRA1-60 (1:100,
StemGent), hNu (1:300, Millipore), Human GFAP (1:1000,
Biolegend), Neuroﬁlament-H (1:10,000, Biolegend).
Proportion of mitotic cells was studied by labeling OPCs
with 10 μM ethynyl deoxyuridine (EdU, Life Technologies)
on day 3 for 24 h. Media was replaced completely the next
day and cells cultured for an additional 48 h in the absence
of EdU before ﬁxation using 4% PFA (Sigma). For detec-
tion, cells were permeabilized using 0.1% saponin (Sigma)
for 2 h and detected using the EdU detection kit (Life
Technologies) according to manufacturer’s instructions.
Image acquisition and analysis
Images were acquired either using a Zeiss ObserverZ1 wide
ﬁeld or Zeiss LSM710 confocal microscope (Carl Zeiss
Microimaging).
Images were converted to TIFF format, corrected for
brightness and contrast, and analyzed using ImageJ (NIH)
or Adobe Photoshop (Adobe Inc.). Figures for preparation
were assembled using Adobe Illustrator (Adobe Inc.)
Cell morphometry
Cellular area was measured in ImageJ using O4 stained
images [61]. Images were thresholded, segmented, and
individual cells outlined using the wand selection tool.
Measurement of internodal lengths was performed using
Simple Neurite Tracer plugin in ImageJ. Electron micro-
scopy measurements were made using the freehand line tool
in ImageJ. Areas were calculated by the in-built area mea-
surement function.
Statistical analysis
Statistical analysis of the data was performed with Prism
(GraphPad software, USA). All tests were performed as
two-tailed. Tractography data was analyzed by MCMC
modeling [29].
For experiments involving iPSCs, each derivation was
considered as n= 1 and data was collected from a minimum
of three derivations for each line. Normality of data dis-
tribution was analyzed by D’Agostino and Shapiro–Wilk’s
tests. Normally distributed data was analyzed using Stu-
dent’s t test or by one-way ANOVA test with Holm–Sidak’s
multiple comparison correction (for >2 groups). Welch’s
correction was applied when standard deviations of the
two groups differed from each other. Quantitative PCR data
was analyzed using nonparametric tests such as
Mann–Whitney or Kruskal–Wallis tests (for 2 and >2
groups, respectively).
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